Potential Benefits of Epitalon Peptide Research into Epitalon peptide therapy continues to evolve
Much of the current research comes from animal and laboratory studies, so findings are still emerging
GSH is exclusively degraded at the extracellular level by cells expressing -glutamyltranspeptidase (GGT), such as those of the hepatobiliary tree and of other organs like the heart, kidney, lungs, pancreas, and seminal vesicles
p38 MAPK, mitogen-activated protein kinases
To verify the clinical significance of the hub targets, the expression of the target proteins was verified in the TCGA database, and the affinity between DEHP and 12 key targets (hub targets with p 0.7, active with a probability 0.7, and inactive with a probability 0 were collected for further analysis
520 This finding emphasizes the importance of considering metabolic status in cancer treatment and the necessity for further research in this area